AU2013359160B2 - Compositions and methods for capture of cellular targets of bioactive agents - Google Patents

Compositions and methods for capture of cellular targets of bioactive agents Download PDF

Info

Publication number
AU2013359160B2
AU2013359160B2 AU2013359160A AU2013359160A AU2013359160B2 AU 2013359160 B2 AU2013359160 B2 AU 2013359160B2 AU 2013359160 A AU2013359160 A AU 2013359160A AU 2013359160 A AU2013359160 A AU 2013359160A AU 2013359160 B2 AU2013359160 B2 AU 2013359160B2
Authority
AU
Australia
Prior art keywords
capture
leu
gly
pro
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013359160A
Other languages
English (en)
Other versions
AU2013359160A1 (en
AU2013359160A2 (en
Inventor
Carolyn W. HITKO
Robin Hurst
Thomas Kirkland
Dieter Klaubert
Poncho Meisenheimer
Nidhi Nath
Rachel F. OHANA
Paul Otto
Marjeta Urh
Harry Tetsuo Uyeda
Keith Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Promega Corp
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Publication of AU2013359160A1 publication Critical patent/AU2013359160A1/en
Publication of AU2013359160A2 publication Critical patent/AU2013359160A2/en
Application granted granted Critical
Publication of AU2013359160B2 publication Critical patent/AU2013359160B2/en
Priority to AU2019201035A priority Critical patent/AU2019201035B9/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2013359160A 2012-12-12 2013-12-12 Compositions and methods for capture of cellular targets of bioactive agents Ceased AU2013359160B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2019201035A AU2019201035B9 (en) 2012-12-12 2019-02-14 Compositions and methods for capture of cellular targets of bioactive agents

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261736426P 2012-12-12 2012-12-12
US61/736,426 2012-12-12
US201361788313P 2013-03-15 2013-03-15
US61/788,313 2013-03-15
PCT/US2013/074756 WO2014093671A1 (en) 2012-12-12 2013-12-12 Compositions and methods for capture of cellular targets of bioactive agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2019201035A Division AU2019201035B9 (en) 2012-12-12 2019-02-14 Compositions and methods for capture of cellular targets of bioactive agents

Publications (3)

Publication Number Publication Date
AU2013359160A1 AU2013359160A1 (en) 2015-07-09
AU2013359160A2 AU2013359160A2 (en) 2015-11-12
AU2013359160B2 true AU2013359160B2 (en) 2018-11-15

Family

ID=50934961

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2013359160A Ceased AU2013359160B2 (en) 2012-12-12 2013-12-12 Compositions and methods for capture of cellular targets of bioactive agents
AU2019201035A Ceased AU2019201035B9 (en) 2012-12-12 2019-02-14 Compositions and methods for capture of cellular targets of bioactive agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2019201035A Ceased AU2019201035B9 (en) 2012-12-12 2019-02-14 Compositions and methods for capture of cellular targets of bioactive agents

Country Status (11)

Country Link
US (2) US9551705B2 (cg-RX-API-DMAC10.html)
EP (1) EP2931305B1 (cg-RX-API-DMAC10.html)
JP (2) JP6484178B2 (cg-RX-API-DMAC10.html)
KR (2) KR102272233B1 (cg-RX-API-DMAC10.html)
CN (1) CN104853767B (cg-RX-API-DMAC10.html)
AU (2) AU2013359160B2 (cg-RX-API-DMAC10.html)
BR (1) BR112015013715A2 (cg-RX-API-DMAC10.html)
CA (1) CA2894432C (cg-RX-API-DMAC10.html)
IL (1) IL239213B (cg-RX-API-DMAC10.html)
SG (1) SG11201504520XA (cg-RX-API-DMAC10.html)
WO (1) WO2014093671A1 (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3434764B1 (en) 2009-12-09 2026-04-08 The Procter & Gamble Company Fabric and home care products
WO2013078244A1 (en) 2011-11-21 2013-05-30 Promega Corporation Carboxy x rhodamine analogs
CN104853767B (zh) 2012-12-12 2017-04-05 普洛麦格公司 用于捕获生物活性剂的细胞标靶的组合物和方法
US11072812B2 (en) 2013-03-15 2021-07-27 Promega Corporation Substrates for covalent tethering of proteins to functional groups or solid surfaces
US10168323B2 (en) 2013-03-15 2019-01-01 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
JP6876002B2 (ja) * 2015-06-05 2021-05-26 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 機能的要素を共有結合により係留させるための細胞透過性、細胞適合性、かつ開裂可能であるリンカー
US10458988B2 (en) * 2017-03-03 2019-10-29 Musc Foundation For Research Development Biotinylated luminescent probe
US12180581B2 (en) 2017-09-18 2024-12-31 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US11709156B2 (en) 2017-09-18 2023-07-25 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved analytical analysis
US12181452B2 (en) 2017-09-18 2024-12-31 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US11709155B2 (en) 2017-09-18 2023-07-25 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US11913944B2 (en) 2019-03-20 2024-02-27 Promega Corporation Photoaffinity probes
US11918936B2 (en) 2020-01-17 2024-03-05 Waters Technologies Corporation Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding
WO2022064447A1 (en) 2020-09-24 2022-03-31 Waters Technologies Corporation Chromatographic hardware improvements for the separation of reactive molecules
JP2022182394A (ja) * 2021-05-28 2022-12-08 独立行政法人国立病院機構 抗原固相化デバイス
EP4370109A4 (en) * 2021-07-14 2025-10-22 Univ Maryland SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) DRUGS, CONJUGATES AND NANOPARTICLES, AND METHODS OF USE THEREOF

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007092579A2 (en) * 2006-02-08 2007-08-16 Promega Corporation Compositions and methods for capturing and analyzing cross-linked biomolecules

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914095A (en) 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
EP0575955B1 (en) 1992-06-22 1999-09-15 Kyowa Hakko Kogyo Co., Ltd. Process for producing staurosporine derivatives
US5756688A (en) 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
KR950703582A (ko) 1992-10-14 1995-09-20 조이스 이. 마임스 킬레이트화 중합체(chelating polymers)
GB9503969D0 (en) 1995-02-28 1995-04-19 Sams Bernard Incrementing mechanism
EP1254179A4 (en) * 2000-01-24 2005-06-01 Univ Columbia IN VIVO SCREEN USING CHEMICAL INDUCTORS
US20020168737A1 (en) 2001-01-24 2002-11-14 Cornish Virginia W. Binding and catalysis screen for high throughput determination of protein function using chemical inducers of dimerization
ES2369542T3 (es) * 2002-07-31 2011-12-01 Seattle Genetics, Inc. Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa.
US7429472B2 (en) * 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
KR20050109934A (ko) 2003-01-31 2005-11-22 프로메가 코포레이션 관능기의 단백질로의 공유 테더링
KR100507796B1 (ko) * 2003-04-03 2005-08-17 한미약품 주식회사 생체내 반감기가 증가된 ｐｅｇ-생리활성 폴리펩티드 동종이량체 결합체 및 이의 제조방법
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
JP5420198B2 (ja) * 2008-06-16 2014-02-19 オリンパス株式会社 タンパク質相互作用解析方法、ポリヌクレオチド、および、組成物
KR100891456B1 (ko) * 2008-11-06 2009-04-01 씨지케이 주식회사 생리활성물질에 대한 세포내 표적물질을 검출하는 방법 및 장치
ES2795287T3 (es) * 2009-05-01 2020-11-23 Promega Corp Luciferasas de Oplophorus sintéticas con mayor emisión de luz
CN103443121B (zh) 2010-11-02 2016-04-20 普罗梅加公司 新型腔肠素底物及其使用方法
CN104853767B (zh) 2012-12-12 2017-04-05 普洛麦格公司 用于捕获生物活性剂的细胞标靶的组合物和方法
US11072812B2 (en) 2013-03-15 2021-07-27 Promega Corporation Substrates for covalent tethering of proteins to functional groups or solid surfaces
US10168323B2 (en) * 2013-03-15 2019-01-01 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
JP6876002B2 (ja) * 2015-06-05 2021-05-26 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 機能的要素を共有結合により係留させるための細胞透過性、細胞適合性、かつ開裂可能であるリンカー

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007092579A2 (en) * 2006-02-08 2007-08-16 Promega Corporation Compositions and methods for capturing and analyzing cross-linked biomolecules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GEORGYI V. LOS ET AL, "HaloTag: A Novel Protein Labeling Technology for Cell Imaging and Protein Analysis", ACS CHEMICAL BIOLOGY, (2008-06-01), vol. 3, no. 6, doi:10.1021/cb800025k, ISSN 1554-8929, pages 373 - 382. *

Also Published As

Publication number Publication date
AU2013359160A1 (en) 2015-07-09
AU2019201035B9 (en) 2021-02-11
JP6484178B2 (ja) 2019-03-13
EP2931305B1 (en) 2018-11-28
US10976312B2 (en) 2021-04-13
JP2019092517A (ja) 2019-06-20
KR20200103867A (ko) 2020-09-02
CN104853767A (zh) 2015-08-19
JP2016502843A (ja) 2016-02-01
AU2019201035B2 (en) 2020-09-03
KR20150093222A (ko) 2015-08-17
CA2894432A1 (en) 2014-06-19
US20170115283A1 (en) 2017-04-27
WO2014093671A1 (en) 2014-06-19
CA2894432C (en) 2022-06-07
KR102227321B1 (ko) 2021-03-12
AU2013359160A2 (en) 2015-11-12
SG11201504520XA (en) 2015-07-30
IL239213B (en) 2020-03-31
JP6999589B2 (ja) 2022-02-04
US20140199712A1 (en) 2014-07-17
IL239213A0 (en) 2015-07-30
EP2931305A1 (en) 2015-10-21
US9551705B2 (en) 2017-01-24
EP2931305A4 (en) 2016-08-17
CN104853767B (zh) 2017-04-05
KR102272233B1 (ko) 2021-07-01
AU2019201035A1 (en) 2019-03-07
BR112015013715A2 (pt) 2017-09-26

Similar Documents

Publication Publication Date Title
AU2019201035B9 (en) Compositions and methods for capture of cellular targets of bioactive agents
JP7393451B2 (ja) 細胞内生体発光共鳴エネルギ移動を用いた生物活性剤による細胞ターゲット結合の認知
US12221648B2 (en) Substrates for covalent tethering of proteins to functional groups or solid surfaces
KR102675860B1 (ko) 구조적 보완에 의한 바이오발광성의 활성화
EP3807419A2 (en) Multipartite luciferase
US10168323B2 (en) Compositions and methods for capture of cellular targets of bioactive agents
JP2018518484A (ja) 機能的要素を共有結合により係留させるための細胞透過性、細胞適合性、かつ開裂可能であるリンカー
Kodadek Synthetic receptors with antibody-like binding affinities
US12187793B2 (en) Single-domain antibody binding to the G protein alpha
WO2026084023A1 (ja) 複数種類の標的分子との複合体を形成し得る目的分子のスクリーニング方法、及び当該スクリーニング方法を含む目的分子の製造方法
CN121941698A (zh) 多肽筛选
US20150045253A1 (en) Method for determining the ability of an antibody to keep cells close to one another

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 23 JUL 2015 .

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 23 JUL 2015

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired